20
Aventis Pharma Sa Antony Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their significant offerings is Sodium cromoglicate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 1999-199 - Rev 01
This Chemical Type CEP, issued on October 06, 2004, remains in force until December 11, 2006, ensuring its reliability within the pharmaceutical industry.
Substance Number 562 associated with this CEP further emphasizes